Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type

Jozef Dingemans; Brian M.J.W. van der Veer; Koen M.F. Gorgels; Volker Hackert; Audrey Y.J. Hensels; Casper D.J. den Heijer; Christian J.P.A Hoebe; Paul H.M. Savelkoul; Lieke B. van Alphen

doi:10.1101/2021.11.22.21266676

Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type

View ORCID ProfileJozef Dingemans, View ORCID ProfileBrian M.J.W. van der Veer, View ORCID ProfileKoen M.F. Gorgels, View ORCID ProfileVolker Hackert, Audrey Y.J. Hensels, View ORCID ProfileCasper D.J. den Heijer, View ORCID ProfileChristian J.P.A Hoebe, View ORCID ProfilePaul H.M. Savelkoul, View ORCID ProfileLieke B. van Alphen

doi: https://doi.org/10.1101/2021.11.22.21266676

Jozef Dingemans

1Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University Medical Centre (MUMC+), PO box 5800, 6202 AZ Maastricht, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jozef Dingemans
For correspondence: jozef.dingemans@mumc.nl

Brian M.J.W. van der Veer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Brian M.J.W. van der Veer

Koen M.F. Gorgels